1 Dong, L., Hu, S. & Gao, J. Discovering drugs to treat coronavirus disease 2019 (COVID- 19). Drug Discoveries & Therapeutics 14, 58-60 (2020).
2 Hu, T. Y., Frieman, M. & Wolfram, J. Insights from nanomedicine into chloroquine efficacy against COVID-19. Nature nanotechnology 15, 247-249, doi:10.1038/s41565- 020-0674-9 (2020).
3 Grein, J. et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. The New England journal of medicine, doi:10.1056/NEJMoa2007016 (2020).
4 Galdiero, S. et al. Silver nanoparticles as potential antiviral agents. Molecules 16, 8894- 8918, doi:10.3390/molecules16108894 (2011).
5 Rai, M., Ingle, A. P., Birla, S., Yadav, A. & Santos, C. A. Strategic role of selected noble metal nanoparticles in medicine. Critical reviews in microbiology 42, 696-719, doi:10.3109/1040841X.2015.1018131 (2016).
6 Cagno, V. et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nature materials 17, 195-203, doi:10.1038/nmat5053 (2018).
7 Lu, L. et al. USA patent (2018).
8 Dunning, J., Thwaites, R. S. & Openshaw, P. J. M. Seasonal and pandemic influenza: 100 years of progress, still much to learn. Mucosal immunology, doi:10.1038/s41385-020- 0287-5 (2020).
9 Kormuth, K. A. & Lakdawala, S. S. Emerging antiviral resistance. Nature microbiology 5, 4-5, doi:10.1038/s41564-019-0639-7 (2020).
10 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-273, doi:10.1038/s41586-020-2012-7 (2020).
11 Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271-280 e278, doi:10.1016/j.cell.2020.02.052 (2020).
12 Rossman, J. S. & Lamb, R. A. Influenza virus assembly and budding. Virology 411, 229- 236, doi:10.1016/j.virol.2010.12.003 (2011).
13 Mori, Y. et al. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale research letters 8, 93, doi:10.1186/1556-276X-8-93 (2013).
14 Ghaffari, H. et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. Journal of biomedical science 26, 70, doi:10.1186/s12929-019-0563-4 (2019).
15 Kim, J. et al. Porous gold nanoparticles for attenuating infectivity of influenza A virus.
Journal of Nanobiotechnology 18 (2020).
16 Arakha, M., Saleem, M., Mallick, B. C. & Jha, S. The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Scientific reports 5, 9578, doi:10.1038/srep09578 (2015).
17 Stoimenov, P. K., Klinger, R. L., Marchin, G. L. & Klabunde, K. J. Metal Oxide Nanoparticles as Bactericidal Agents. Langmuir 18, 6679–6686 (2002).
18 Lilly, M., Dong, X., McCoy, E. & Yang, L. Inactivation of Bacillus anthracis spores by single-walled carbon nanotubes coupled with oxidizing antimicrobial chemicals. Environmental science & technology 46, 13417-13424, doi:10.1021/es303955k (2012).
19 Yamada, M., Foote, M. & Prow, T. W. Therapeutic gold, silver, and platinum nanoparticles. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 7, 428-445, doi:10.1002/wnan.1322 (2015).
20 Yahyaei, B., Nouri, M., Bakherad, S., Hassani, M. & Pourali, P. Effects of biologically produced gold nanoparticles: toxicity assessment in different rat organs after intraperitoneal injection. AMB Express 9, 38, doi:10.1186/s13568-019-0762-0 (2019).
21 Meng, J., Zhou, X., Yang, J., Qu, X. & Cui, S. Exposure to low dose ZnO nanoparticles induces hyperproliferation and malignant transformation through activating the CXCR2/NF-kappaB/STAT3/ERK and AKT pathways in colonic mucosal cells. Environmental pollution 263, 114578, doi:10.1016/j.envpol.2020.114578 (2020).
22 Murphy, C. J. et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging.
Accounts of chemical research 41, 1721-1730, doi:10.1021/ar800035u (2008).
23 Ma, J. W. et al. Efficacy and Safety Evaluation of a Chlorine Dioxide Solution. International journal of environmental research and public health 14, doi:10.3390/ijerph14030329 (2017).